Web notes  
December 2013

[Oncology archives]

1. Campian J, Sarai G, Ye X, Marur S, Grossman SA. The association between severe treatment-related lymphopenia and progression free survival in patients with newly diagnosed squamous cell head and neck cancer. Head Neck. 2013 Oct 31. doi: 10.1002/hed.23535. [Epub ahead of print]
Key words: lymphopenia, head and neck cancer

2. Forde PM, Reiss KA, Zeidan AM, Brahmer JR. What lies within: novel strategies in immunotherapy for non-small cell lung cancer. Oncologist. 2013 Oct 8. [Epub ahead of print]
Key words: lung cancer, immunotherapy

3. Paller CJ, Olatoye D, Xie S, Zhou X, Denmeade SR, Eisenberger MA, Antonarakis ES, Carducci MA, Rosner GL. The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer. Prostate Cancer Prostatic Dis. 2013 Oct 8. doi: 10.1038/pcan.2013.40. [Epub ahead of print]
Key words: prostate cancer, PSA, biochemical

4. Papadopoulos N, Kinde I, Munari E, Faraj SF, Hruban RH, Schoenberg MP, Bivalacqua T, Allaf ME, Springer S, Wang Y, Diaz LA Jr, Kinzler KW, Vogelstein B, Netto GJ. TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine. Cancer Res. 2013 Oct 11. [Epub ahead of print]
Key words: urothelial, urine, neoplasia, biomarkers

5. Suzman DL, Eisenberger MA. Determining the optimal treatment for metastatic castration-resistant prostate cancer: age should not be a factor. Eur Urol. 2013 Oct 16. doi:pii: S0302-2838(13)01075-0. 10.1016/j.eururo.2013.10.002. [Epub ahead of print]
Key words: metastatic, castration, prostate cancer

6. Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M, Fitzgibbons P, Hanna W, Jenkins RB, Mangu PB, Paik S, Perez EA, Press MF, Spears PA, Vance GH, Viale G, Hayes DF. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update. Arch Pathol Lab Med. 2013 Oct 7. [Epub ahead of print]
Key words: breast cancer, epidermal

7. Wrangle J, Wang W, Koch A, Easwaran H, Mohammad HP, Vendetti F, Vancriekinge W, Demeyer T, Du Z, Parsana P, Rodgers K, Yen RW, Zahnow CA, Taube JM, Brahmer JR, Tykodi SS, Easton K, Carvajal RD, Jones PA, Laird PW, Weisenberger DJ, Tsai S, Juergens RA, Topalian SL, Rudin CM, Brock MV, Pardoll D, Baylin SB. Alterations of immune response of non-small cell lung cancer with azacytidine. Oncotarget. 2013 Oct 25. [Epub ahead of print]
Key words: lung cancer, azacytine, immune

9. Yang X, Sexauer A, Levis M. Bone marrow stroma-mediated resistance to FLT3 inhibitors in FLT3-ITD AML is mediated by persistent activation of extracellular regulated kinase. Br J Haematol. 2013 Oct 10. doi: 10.1111/bjh.12599. [Epub ahead of print]
Key words: stroma, FLT3, extracellular

Return to top of Publications - Oncology

Search Publications
December 2013 articles:
Visit Animal Care and Use Committee Website
Current Classes
Funding from Foundations/Private Sources
Gruber Foundation Invites Nominations for 2014 Neuroscience Award
Camille Dreyfus Teacher-Scholar Awards Program for 2014
Mary Kay Foundation - Cancer Research Grant Program for 2014
NSF 13-517 - Major Research Instrumentation (MRI) Program for 2014
Funding for Prostate Cancer Research
New Doris Duke Charitable Foundation Grant Competition: 2014 Clinical Research Mentorship
American Asthma Association
Dean's Research Integrity Lectures

This Month's Departmental Listings

Upcoming Deadlines for December, January and February

Genetic Resources Core Facility (GCRF)


JHM AppointmentsEmployment @ JHM | Finding a Doctor | Disclaimer | Maps & Directions | Contact JHM 


                                                                                                                                                           The Web Center